Back

Notification report

Full notification file


General information

Notification Number
B/ES/12/09

Member State to which the notification was sent
Spain

Date of acknowledgement from the Member State Competent Authority
31/01/2012

Title of the Project
Safety and Immunogenicity of ChAdV63.HIVconsv and MVA.HIVconsv candidate HIV-1 vaccines in recently HIV-1 infected individuals with early viral suppression after initiation of antiretroviral therapy (HAART)

Proposed period of release:
01/01/2012 to 31/12/2012

Name of the Institute(s) or Company(ies)
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Carretera de Canyet s/n
08916 Badalona (Barcelona);


3. Is the same GMO release planned elsewhere in the Community?
No

Has the same GMPt been notified elsewhere by the same notifier?
Yes

If yes, notification number(s):


GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
The final GMO ChAdV63.HIVconsv is a life recombinant replication-incompetent
chimpanzee adenovirus (ChAdV63) that harbors the codifying sequence for the HIV-1
specific T-cell immunogen HIVconsv.

Information relating to the recipient or parental organisms from wich the GMO is derived

Common Name	Genus	Species	Subspecies	Strain	Pathovar
Chimpanzee adenovirus 63	Mastadenovirus	-	-	Serotype 63 from chimpanzee adenovirus

European Commission administrative information

Consent given by the Member State Competent Authority:
Yes
18/06/2012 00:00:00
Remarks: